Xeris Pharmaceuticals (United States)

Xeris Pharmaceuticals is a specialty pharmaceutical company developing ready-to-use injectable and infusible drug formulations. The company’s XeriSol and XeriJect technologies enable room-temperature stable formulations of peptides and proteins. Key products include Gvoke (glucagon) for severe hypoglycemia and Recorlev for Cushing’s syndrome. Xeris’s formulation expertise creates patient-friendly alternatives to complex injectable medications.